Pulmonary oedema without critical increase in left atrial pressure in acute myocardial infarction.

Twelve patients with acute myocardial infarction and radiological evidence of pulmonary oedema were observed in whom the left atrial pressure, measured indirectly as pulmonary artery end-diastolic pressure, was not critically increased (range 5-12 mm Hg with reference to sternal angle). Eight of the patients had been treated with frusemide, but only six had responded: hence in at least half of the series diuresis could not account for the anomalous finding. Six patients with low cardiac output were given infusions to expand plasma volume. Appreciable increments in mean values for cardiac index (1.6 to 2.0 1/min/m2), stroke index (18 to 23 ml/beat/m2), mean arterial pressure (65 to 86 mm Hg), and pulmonary artery end-diastolic pressure (8 to 15 mm Hg) were recorded. This group, and the remaining six patients with higher cardiac output, survived to leave hospital. Delay in radiographic clearing after a fall of left atrial pressure was a possible explanation for the relatively low pulmonary artery end-diastolic pressures, especially in the patients treated successfully with diuretics. Other mechanisms, such as alterations in pulmonary vascular permeability, might also have contributed to the syndrome. Pulmonary oedema without a critical increase in the left atrial pressure is unusual in acute myocardial infarction but the therapeutic implications are important. Withdrawal;of diuretics may be indicated, and in some cases expansion of plasma volume may lead to striking clinical improvement.     

Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition.

Fenfluramine produced a rapid hyperthermic effect in rats housed in a warm (26–28 °C) environment. Drugs with known activity on serotonin-mediated pathways were the most effective antagonists of this hyperthermia. Among several anti-psychotic agents, clozapine was unique by virtue of its potent and specific antagonism of fenfluramine-induced hyperthermia. It is suggested that this serotonin blocking activity of clozapine may help to account for the lack of extrapyramidal symptoms (EPS) following administration of the drug to man.     

RPN2与肝癌患者预后及对肝癌细胞生长的作用

目的:探讨核糖蛋白2(ribophorin II,RPN2)在肝细胞肝癌(HCC)组织中的表达和对HCC患者生存的影响,同时分析RPN2对肝癌HepG2细胞生长和克隆形成的作用。方法:应用免疫组化方法和HCC公共芯片数据,从蛋白和m RNA水平检测HCC组织中RPN2的表达,同时分析RPN2与HCC患者临床参数的关系及预后相关性;进一步利用MTS法和克隆形成实验在肝癌HepG2细胞中检测RPN2对细胞生长的作用。结果:98例肝癌组织中,RPN2阳性表达率88.78%,对应癌旁肝组织中,RPN2阳性表达率74.49%;癌组织中RPN2染色评分为5.80±3.15,癌旁肝组织RPN2染色评分为2.13±1.59,肝癌组织中RPN2表达显著上调(P0.001)。3个肝癌公共芯片数据(共522例肝癌)中RPN2的m RNA表达水平同样显著升高(均P0.001)。98例肝癌患者RPN2表达水平与肿瘤直径(P=0.004)、门脉侵袭(P=0.012)和TNM分期(P=0.009)相关;RPN2高表达的患者总体生存期(OS)和无复发生存期(RFS)较RPN2低表达的患者短(OS:P=0.027;RFS:P=0.036)。肝癌HepG2细胞转染RPN2小干扰RNA后,细胞生长能力显著受抑制。结论:RPN2在肝癌中表达显著升高,RPN2的表达与肝癌的恶性进展有关,RPN2显著促进肝癌细胞生长。     

中国植被分类系统修订方案

为了推动《中国植被志》研编工作, 该文回顾了中国植被分类系统的发展过程和主要阶段性成果, 提出了作为《中国植被志》研编技术框架组成部分的中国植被分类系统修订方案, 对各植被型组及各植被型进行了简单定义和描述, 并针对中国植被分类系统若干问题, 特别就中国植被分类系统总体框架、混交林的界定以及土壤在植被分类中的重要性等问题进行了讨论。1960年侯学煜在《中国的植被》中首次提出了中国植被分类的原则和系统, 1980年出版的《中国植被》制定了分类等级和划分依据等更加完善的系统, 之后《中国植被及其地理格局——中华人民共和国1:1 000 000植被图说明书》和《中国植物区系与植被地理》以及很多省区的植被专著对该系统进行过修订。2017年宋永昌在《植被生态学》中提出了一个分类等级单位调整的方案。本次提出的中国植被分类系统修订方案基本沿用《中国植被》的植被分类原则、分类单位及系统, 采用“植物群落学-生态学”分类原则, 主要以植物群落特征及其与环境的关系作为分类依据, 包含三级主要分类单位, 即植被型(高级单位)、群系(中级单位)和群丛(低级单位); 在三个主要分类单位之上分别增加辅助单位植被型组、群系组和群丛组, 在植被型和群系之下主要根据群落的生态差异和实际需要可再增加植被亚型或亚群系。修订方案包含了森林、灌丛、草本植被(草地)、荒漠、高山冻原与稀疏植被、沼泽与水生植被(湿地)、农业植被、城市植被和无植被地段9个植被型组, 划分为48个植被型(含30个自然植被型、12个农业植被型、5个城市植被型和无植被地段)。自然植被中有23个植被型进一步划分出了81个植被亚型。